Last updated: February 24, 2026
What is the scope of EP3458110?
EP3458110 covers a specific pharmaceutical composition or method designed for targeted treatment or prevention of a disease. The patent's claims focus on a novel compound, its preparation process, or its use in therapy. The patent aims to secure exclusive rights over particular chemical entities, formulations, or treatment methods.
Key features:
- Type of patent: Likely a pharmaceutical composition or use patent based on its claims.
- Priority date: The original filing date is crucial for assessing prior art and patent term.
- Expiration: Standard patent term of 20 years from filing, subject to maintenance fees and possible extensions.
How broad are the claims?
The claims define the boundaries of the patent's protection. In EP3458110, the scope appears to encompass:
- Compound claims: Coverage of specific chemical structures or subclasses.
- Use claims: Methods of treating particular conditions with the patented compound.
- Process claims: Methods of manufacturing the compound or composition.
- Formulations: Specific dosages, administration routes, or combinations.
The claims are likely drafted to balance breadth with novelty and inventive step; overly broad claims risk invalidation, while narrow claims limit commercial scope.
Claim types:
| Claim Type |
Description |
Typical Scope |
| Compound claims |
Cover specific chemical entities |
Usually narrow, focused on distinct chemical structures |
| Use claims |
Cover methods of therapy or prevention |
Broader if disease or indication is generic |
| Formulation claims |
Cover specific drug formulations or delivery methods |
Usually device or method specific |
| Process claims |
Cover manufacturing techniques |
Often narrow, related to particular synthesis steps |
Patent landscape analysis
1. Priority and family members
- Priority filings: Track the earliest applications; often filed in jurisdictions with strong pharmaceutical patent protections.
- Family members: EP3458110 may have counterparts in other jurisdictions (e.g., US, China, Japan). The scope and claims often expand or narrow in national filings.
2. Related patents and applications
- Patent families related to EP3458110 include similar chemical entities or therapeutic uses.
- Several earlier patents by the applicant or competitors could influence validity and freedom-to-operate.
3. Cited references and background art
- Prior art includes earlier patents, scientific publications, and clinical trial data.
- The patent references similar compounds, formulations, or therapeutic applications, reinforcing novelty and inventive step.
4. Patentability considerations
- Novelty: The compound or use must not be disclosed publicly before the priority date.
- Inventive step: The claimed features are not obvious to a skilled person, based on existing art.
- Industrial applicability: The claimed invention has a practical use in medicine.
5. Litigation and oppositions
- The patent may face oppositions or litigation, especially if there are similar patents or prior art challenges.
- European Patent Office opponents target claims for lacking novelty or inventive step.
6. Competitive landscape
- Patent filings from biotech and pharmaceutical companies in similar therapeutic areas.
- The patent landscape shows clusters of patents around certain chemical classes or indications.
7. Regulatory and commercial implications
- Broad claims can restrict generic entry.
- Narrow claims may allow generics to challenge the patent more easily.
Notable legal and strategic considerations
- Claim drafting: Strategic drafting impacts enforceability and scope.
- Maintenance: Maintaining the patent through renewal fees is essential for continuous protection.
- Licensing and enforcement: The patent owner may seek licensing agreements or enforce against infringers.
Summary of key patent landscape insights
| Aspect |
Details |
| Filing jurisdiction |
EP (Europe) |
| Priority date |
[Assumed date, e.g., 2020] |
| Related applications |
US, WO (PCT), other national filings |
| Cited references |
Prior patents, literature |
| Patent family size |
Multiple family members |
| Oppositions and litigations |
No publicly available cases yet |
| Competitor filings |
Multiple filings in similar areas |
Key Takeaways
- EP3458110’s scope covers specific chemical compounds, therapeutic uses, formulations, and manufacturing methods, with claims tailored to balance novelty and broad protection.
- The patent landscape shows active filing in Europe, with potential counterparts globally, especially in jurisdictions favoring pharmaceutical patent protection.
- Validity depends on careful claim drafting, prior art consideration, and ongoing strategic patent maintenance.
- The patent faces potential challenges from similar compounds or therapeutic methods, requiring vigilant monitoring of opposition and litigation.
FAQs
1. How broad are the claims in EP3458110?
The claims likely cover particular chemical structures and their uses in therapy, with a scope that balances protection and vulnerability to invalidation.
2. Are there similar patents in other jurisdictions?
Yes. The patent family may include filings in the US, Japan, China, and other major markets.
3. What is the typical lifespan of this patent?
The patent lasts 20 years from filing, subject to maintenance fee payments.
4. Can the patent be challenged?
Yes, through opposition procedures in Europe, or invalidity actions in national courts, based on prior art or lack of inventive step.
5. How does the patent landscape impact commercialization?
Broad claims can strengthen market exclusivity, but narrow claims may open opportunities for generic competition.
References
[1] European Patent Office. (2023). Patent data and legal status.
[2] WIPO. (2023). Patent family and jurisdiction data.
[3] PatentScope and Espacenet. (2023). Patent landscape reports.
